Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections

SARS-CoV-2 antibody assays are used for epidemiological studies and for the assessment of vaccine responses in highly vulnerable patients. So far, data on cross-reactivity of SARS-CoV-2 antibody assays is limited. Here, we compared four enzyme-linked immunosorbent assays (ELISAs; Vircell SARS-CoV-2...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Eur J Clin Microbiol Infect Dis
Auteurs principaux: Huber, Timo, Steininger, Philipp, Irrgang, Pascal, Korn, Klaus, Tenbusch, Matthias, Diesch, Katharina, Achenbach, Susanne, Kremer, Andreas E., Werblow, Marissa, Vetter, Marcel, Bogdan, Christian, Held, Jürgen
Format: Artigo
Langue:Inglês
Publié: Springer Berlin Heidelberg 2021
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8189710/
https://ncbi.nlm.nih.gov/pubmed/34109500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10096-021-04285-4
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires